88IV - PR Newswire Asia's news


Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date . Dr. Coulie brings more than 25 years of international biopharma leadership ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced solid tumor patients ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026 HONG KONG , May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of 'SNB-101' SEONGNAM, South Korea , May 15, 2026 /PRNewswire/ -- SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
DeepQure Reports Encouraging Clinical Data from World's First Extravascular RDN System at AUA 2026 WASHINGTON , May 15, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, announced the completion of its featured presentation at the American Urological Association (AUA) Innovation ... 2026-05-15T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA Clearance Recognises Cell Dx -Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence ... 2026-05-14T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer PRINCETON, N.J. , May 14, 2026 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical-stage biopharmaceutical company developing differentiated oncology therapies designed to translate cutting-edge innovation ... 2026-05-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Origin Agritech to Hold Business Update & First Half Fiscal Year 2026 Earnings Conference Call on May 22 at 8 a.m. ET BEIJING , May 14, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, will announce its financial ... 2026-05-14T Agriculture Banking/Financial Service Biotechnology Chemical
EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd, a new Australian medtech company NinaMED Pty Ltd secures a license ... 2026-05-14T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control - Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial ... 2026-05-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology